Target Gene/Pathway Pathway / Gene

  

Search results

No. KEGG GENES KEGG PATHWAY KEGG DRUG DrugBank Disease ID
1 HDAC6 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
2 HDAC5 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
3 CDK4 [1] Viral carcinogenesis D10688 Abemaciclib [1] 34
4 CDK6 [1] Viral carcinogenesis D10688 Abemaciclib [1] 34
5 CCR4 [2] Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09761 Mogamulizumab [1] 26
6 CCR5 [2] Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D06670 Maraviroc [2] 46, 84
7 CCR5 [2] Viral protein interaction with cytokine and cytokine receptor, Viral carcinogenesis D09878 Cenicriviroc [1] 94
8 HDAC1 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
9 HDAC2 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
10 HLA-A [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
11 HLA-B [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
12 HLA-C [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
13 HLA-E [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
14 HLA-F [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
15 HLA-G [2] Viral carcinogenesis, Viral myocarditis D04318 Glatiramer [4] 2, 13, 96, 156
16 JAK1 [1] Viral carcinogenesis D09959 Ruxolitinib [1] 228
17 JAK1 [1] Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
18 JAK1 [1] Viral carcinogenesis D10308 Baricitinib [13] 41, 46, 49, 50, 51, 53, 93, 107, 162, 265, 268, 269, 325
19 JAK1 [1] Viral carcinogenesis D10653 Peficitinib [1] 46
20 JAK1 [1] Viral carcinogenesis D10871 Filgotinib [6] 46, 53, 96, 97, 222, 271
21 JAK1 [1] Viral carcinogenesis D10944 Itacitinib [5] 46, 51, 60, 97, 228
22 JAK1 [1] Viral carcinogenesis D10994 Upadacitinib [8] 40, 41, 46, 49, 96, 97, 107, 271
23 JAK3 [1] Viral carcinogenesis D09970 Tofacitinib [15] 11, 40, 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 107, 256, 271
24 JAK3 [1] Viral carcinogenesis D10653 Peficitinib [1] 46
25 NFKB1 [2] Yersinia infection, Viral carcinogenesis D01146 Iguratimod [4] 46, 51, 53, 271
26 HDAC7 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
27 PIK3CA [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
28 PIK3CB [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
29 PIK3CD [2] Yersinia infection, Viral carcinogenesis D11158 Leniolisib [2] 53, 65
30 PIK3CD [2] Yersinia infection, Viral carcinogenesis D11437 Parsaclisib [3] 35, 53, 61
31 HDAC8 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
32 RELA [2] Yersinia infection, Viral carcinogenesis D12181 Edasalonexent [1] 113
33 SRC [2] Yersinia infection, Viral carcinogenesis D03252 Bosutinib [2] 2, 67
34 SRC [2] Yersinia infection, Viral carcinogenesis D03658 Dasatinib [2] 51, 85
35 SRC [2] Yersinia infection, Viral carcinogenesis D06414 Dasatinib [2] 51, 85
36 SRC [2] Yersinia infection, Viral carcinogenesis D09664 Saracatinib [3] 6, 89, 272
37 SYK [1] Viral carcinogenesis D09347 Fostamatinib [4] 46, 49, 61, 66
38 C3 [1] Viral carcinogenesis D11613 Pegcetacoplan [3] 2, 62, 222
39 HDAC11 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
40 HDAC10 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
41 HDAC3 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
42 HDAC9 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96
43 HDAC4 [1] Viral carcinogenesis D06320 Vorinostat [3] 19, 75, 96